Michael Novak, MD, Ophthalmology, Beachwood, OH, University Hospitals Parma Medical Center

MichaelANovakMD

Ophthalmology Beachwood, OH

Retinal Disease

Retina Associates of Cleveland

Dr. Novak is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Novak's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Ophthalmology, 1978 - 1982
  • Case Western Reserve University - University Hospitals
    Case Western Reserve University - University HospitalsInternship, Internal Medicine, 1977 - 1978
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1977
  • Adelbert College, Case Western Reserve UniversityBA, 1969 - 1973

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1983 - 2022
  • PA State Medical License
    PA State Medical License 1983 - 1984
  • MD State Medical License
    MD State Medical License 1980 - 1983
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Best Doctors in America 2011
  • Best Doctors in Cleveland Cleveland Magazine, 2011
  • Honor Award American Academy of Ophthalmology, 1992
  • Join now to see all

Clinical Trials

Publications & Presentations

Journal Articles

  • VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
    Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, JAMA Ophthalmol, 1/1/2014
  • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial  
    Age-Related Eye Disease Study 2 Research Group, JAMA, 5/15/2013
  • Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials  
    Maguire MG, Daniel E, Shah AR, Grunwald JE, et al; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group), Ophthalmology, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Impact of Lucentis on psychological morbidity in patients with macular edema and neovascularization secondary to retinal vein occlusion.
    Singerman LJ, Himmelman DR, Singerman B, Thomas A, Newman L, Coney JM, Schartman JP, Novak MA, Program#/Poster# 5466/A662. Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, FL, 5/1/2012

Lectures

  • Results of the Age-Related Eye Disease Study 2 (AREDS2). 
    Warren, OH - 9/10/2013
  • Retinal update on anti-VEGF therapy (with Drs. Coney, Miller, Rao, Schartman, and Zegarra). 
    Vermilion, OH - 12/20/2012
  • Lifestyle modifications to prevent the development & progression of macular degeneration. 
    Case Western Reserve University School of Medicine, Cleveland, OH - 11/8/2012
  • Join now to see all

Professional Memberships

Hospital Affiliations